Microvesicles from patients with acute coronary syndrome enhance platelet aggregation

References

• Burger D, Schock S, Thompson CS, et al. Microparticles: biomarkers and beyond. Clin Sci. 2013;124(7):423–441.
   PubMed Web of Science ®Google Scholar
• Mavroudis CA, Eleftheriou D, Hong Y, et al. Microparticles in acute coronary syndrome. Thromb Res. 2017;156:109–116.
   PubMed Web of Science ®Google Scholar
• Biasucci LM, La Rosa G, Pedicino D, et al. Where does inflammation fit? Curr Cardiol Rep. 2017;19(9):84.
   PubMed Web of Science ®Google Scholar
• Mobarrez F, Sjovik C, Soop A, et al. CD40L expression in plasma of volunteers following LPS administration: a comparison between assay of CD40L on platelet microvesicles and soluble CD40L. Platelets. 2015;26(5):486–490.
   PubMed Web of Science ®Google Scholar
• Skeppholm M, Mobarrez F, Malmqvist K, et al. Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost. 2012;107(6):1122–1129.
   PubMed Web of Science ®Google Scholar
• Paues Goranson S, Thalin C, Lundstrom A, et al. Circulating H3Cit is elevated in a human model of endotoxemia and can be detected bound to microvesicles. Sci Rep. 2018;8:12641.
   PubMed Web of Science ®Google Scholar
• Barteneva NS, Fasler-Kan E, Bernimoulin M, et al. Circulating microparticles: square the circle. BMC Cell Biol. 2013;14(1):23.
   PubMed Web of Science ®Google Scholar
• Burnouf T, Chou ML, Goubran H, et al. An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful? Transfus Apher Sci. 2015;53(2):137–145.
   PubMed Web of Science ®Google Scholar
• Hartopo AB, Puspitawati I, Gharini PP, et al. Platelet microparticle number is associated with the extent of myocardial damage in acute myocardial infarction. Arch Med Sci. 2016;12:529–537.
   PubMed Web of Science ®Google Scholar
• Melki I, Tessandier N, Zufferey A, et al. Platelet microvesicles in health and disease. Platelets. 2017;28(3):214–221.
   PubMed Web of Science ®Google Scholar
• Kafian S, Mobarrez F, Wallen H, et al. Association between platelet reactivity and circulating platelet-derived microvesicles in patients with acute coronary syndrome. Platelets. 2015;26(5):467–473.
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Collins R, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849–1860.
   PubMed Web of Science ®Google Scholar
• Sibbing D, Braun S, Jawansky S, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost. 2008;99:121–126.
   PubMed Web of Science ®Google Scholar
• Toth O, Calatzis A, Penz S, et al. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost. 2006;96(6):781–788.
   PubMed Web of Science ®Google Scholar
• Sun C, Zhao WB, Chen Y, et al. Higher plasma concentrations of platelet microparticles in patients with acute coronary syndrome: a systematic review and meta-analysis. Can J Cardiol. 2016;32:1325.
   PubMed Web of Science ®Google Scholar
• Hartford M, Wiklund O, Hultén LM, et al. Interleukin-18 as a predictor of future events in patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol. 2010;30(10):2039–2046.
   PubMed Web of Science ®Google Scholar
• Mobarrez F, He S, Broijersen A, et al. Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. Thromb Haemost. 2011;106(2):344–352.
   PubMed Web of Science ®Google Scholar
• Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol. 2009;53(10):849–856.
   PubMed Web of Science ®Google Scholar
• Sibbing D, Steinhubl SR, Schulz S, et al. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window. J Am Coll Cardiol. 2010;56(4):317–318.
   PubMed Web of Science ®Google Scholar
• Armstrong PC, Dhanji AR, Truss NJ, et al. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness. Thromb Haemost. 2009;102(4):772–778.
   PubMed Web of Science ®Google Scholar
• Lordkipanidze M, Lowe GC, Kirkby NS, et al. Characterization of multiple platelet activation pathways in patients with bleeding as a high-throughput screening option: use of 96-well Optimul assay. Blood. 2014;123(8):e11–e22.
   PubMed Web of Science ®Google Scholar
• Li S, Wei J, Zhang C, et al. Cell-derived microparticles in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Cell Physiol Biochem. 2016;39(6):2439–2450.
   PubMedGoogle Scholar
• Vazzana N, Ranalli P, Cuccurullo C, et al. Diabetes mellitus and thrombosis. Thromb Res. 2012;129(3):371–377.
   PubMed Web of Science ®Google Scholar
• Trip MD, Cats VM, van Capelle FJ, et al. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 1990;322(22):1549–1554.
   PubMed Web of Science ®Google Scholar
• Breddin HK, Lippold R, Bittner M, et al. Spontaneous platelet aggregation as a predictive risk factor for vascular occlusions in healthy volunteers? Results of the HAPARG Study. Haemostatic parameters as risk factors in healthy volunteers. Atherosclerosis. 1999;144(1):211–219.
   PubMed Web of Science ®Google Scholar
• Iwase E, Tawata M, Aida K, et al. A cross-sectional evaluation of spontaneous platelet aggregation in relation to complications in patients with type II diabetes mellitus. Metabolism. 1998;47(6):699–705.
   PubMed Web of Science ®Google Scholar
• Tantry US, Bonello L, Aradi D, et al. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol. 2013;62(24):2261–2273.
   PubMed Web of Science ®Google Scholar
• Bampalis VG, Brantl SA, Siess W. Why and how to eliminate spontaneous platelet aggregation in blood measured by multiple electrode aggregometry. Thromb Haemost. 2012;10(8):1710–1714.
   Web of Science ®Google Scholar
• Kakouros N, Rade JJ, Kourliouros A, et al. Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011;2011:1.
   Web of Science ®Google Scholar
• Fan GQ, Qin RR, Li YH, et al. Endothelial cells microparticle-associated protein disulfide isomerase promotes platelet activation in metabolic syndrome. Oncotarget. 2016;7(50):83231–83240.
   PubMedGoogle Scholar
• Flaumenhaft R. Protein disulfide isomerase as an antithrombotic target. Trends Cardiovasc Med. 2013;23(7):264–268.
   PubMed Web of Science ®Google Scholar